Biogen Pharmachem Industries Limited (BOM:531752)
India
· Delayed Price · Currency is INR 0.620
-0.010 (-1.59%)
At close: Mar 9, 2026
BOM:531752 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Operating Revenue | - | - | - | - | 24.74 | 16.23 | Upgrade
|
| Other Revenue | 36.91 | 11.98 | 7.89 | 2.5 | 0.07 | - | Upgrade
|
| Revenue | 36.91 | 11.98 | 7.89 | 2.5 | 24.81 | 16.23 | Upgrade
|
| Revenue Growth (YoY) | - | 51.78% | 215.26% | -89.91% | 52.90% | - | Upgrade
|
| Cost of Revenue | - | - | - | - | 20.15 | 14.81 | Upgrade
|
| Gross Profit | 36.91 | 11.98 | 7.89 | 2.5 | 4.66 | 1.42 | Upgrade
|
| Selling, General & Admin | 2.73 | 1.68 | 0.84 | 1.75 | 0.54 | 0.14 | Upgrade
|
| Other Operating Expenses | 9.02 | 13 | 3.67 | 2.72 | 1.08 | 1.23 | Upgrade
|
| Operating Expenses | 11.75 | 14.68 | 4.51 | 4.46 | 1.62 | 1.37 | Upgrade
|
| Operating Income | 25.16 | -2.7 | 3.38 | -1.96 | 3.04 | 0.05 | Upgrade
|
| Other Non Operating Income (Expenses) | 0 | - | - | - | - | -0 | Upgrade
|
| EBT Excluding Unusual Items | 25.16 | -2.7 | 3.38 | -1.96 | 3.04 | 0.05 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | -3.12 | -16.08 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 15.92 | 6.63 | - | - | Upgrade
|
| Pretax Income | 25.16 | -2.7 | 19.31 | 4.67 | -0.09 | -16.03 | Upgrade
|
| Income Tax Expense | 0.23 | 0.23 | - | 0.11 | - | - | Upgrade
|
| Net Income | 24.93 | -2.93 | 19.31 | 4.56 | -0.09 | -16.03 | Upgrade
|
| Net Income to Common | 24.93 | -2.93 | 19.31 | 4.56 | -0.09 | -16.03 | Upgrade
|
| Net Income Growth | - | - | 323.86% | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 1,088 | 653 | 653 | 653 | 653 | 653 | Upgrade
|
| Shares Outstanding (Diluted) | 1,088 | 653 | 653 | 653 | 653 | 653 | Upgrade
|
| EPS (Basic) | 0.02 | -0.00 | 0.03 | 0.01 | -0.00 | -0.02 | Upgrade
|
| EPS (Diluted) | 0.02 | -0.00 | 0.03 | 0.01 | -0.00 | -0.02 | Upgrade
|
| EPS Growth | - | - | 323.90% | - | - | - | Upgrade
|
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 18.79% | 8.75% | Upgrade
|
| Operating Margin | 68.16% | -22.54% | 42.87% | -78.19% | 12.24% | 0.31% | Upgrade
|
| Profit Margin | 67.55% | -24.44% | 244.67% | 181.98% | -0.35% | -98.80% | Upgrade
|
| EBIT | 25.16 | -2.7 | 3.38 | -1.96 | 3.04 | 0.05 | Upgrade
|
| EBIT Margin | 68.16% | -22.54% | 42.87% | -78.19% | 12.24% | 0.31% | Upgrade
|
| Effective Tax Rate | 0.91% | - | - | 2.42% | - | - | Upgrade
|
| Revenue as Reported | 36.91 | 11.98 | 23.82 | 9.13 | 24.81 | 16.23 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.